Corient Private Wealth LLC Has $9.72 Million Position in iShares Biotechnology ETF (NASDAQ:IBB)

Corient Private Wealth LLC lowered its position in iShares Biotechnology ETF (NASDAQ:IBB) by 11.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 75,334 shares of the financial services provider’s stock after selling 9,680 shares during the quarter. Corient Private Wealth LLC owned approximately 0.16% of iShares Biotechnology ETF worth $9,721,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in IBB. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the third quarter valued at $29,000. HHM Wealth Advisors LLC lifted its stake in iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares during the last quarter. Bradley & Co. Private Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the fourth quarter valued at $32,000. Newbridge Financial Services Group Inc. acquired a new stake in iShares Biotechnology ETF in the fourth quarter valued at $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in iShares Biotechnology ETF in the fourth quarter valued at $34,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $134.57 on Thursday. The company has a fifty day moving average price of $136.25 and a two-hundred day moving average price of $139.54. The stock has a market cap of $6.14 billion, a P/E ratio of 27.83 and a beta of 0.77. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th will be paid a dividend of $0.1212 per share. The ex-dividend date of this dividend is Tuesday, March 18th. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.